Beijing Tong Ren Tang Chinese Medicine マネジメント
マネジメント 基準チェック /04
現在、CEO に関する十分な情報がありません。
主要情報
Wang Chi
最高経営責任者
n/a
報酬総額
| CEO給与比率 | n/a |
| CEO在任期間 | less than a year |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | less than a year |
| 取締役会の平均在任期間 | 2.3yrs |
経営陣の近況
Recent updates
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up
Oct 04
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders
Sep 06Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?
Sep 02Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk
Feb 05Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Jan 03A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Sep 28Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today
Jul 12Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?
Mar 29Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28
Apr 28Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28
Mar 25Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?
Oct 27Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 28Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Mar 11What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Feb 04Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?
Jan 18
Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?
Dec 29Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Dec 11Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 23CEO（最高経営責任者
Wang Chi (49 yo)
less than a year
在職期間
Mr. Wang Chi is Executive Director and Chief Executive Officer of Beijing Tong Ren Tang Chinese Medicine Company Limited from May 10, 2024. Mr. Chi has experience in Medical and Pharmaceutical industry. Mr...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | データなし | データなし | |
| Executive Director & Executive Deputy GM | less than a year | HK$975.00k | 0.0073% HK$ 482.7k | |
| CEO & Executive Director | less than a year | データなし | データなし | |
| CFO & Company Secretary | 4.5yrs | データなし | データなし | |
| Deputy GM & General Counsel | no data | データなし | データなし |
0.7yrs
平均在職期間
50yo
平均年齢
経験豊富な経営陣: 3613の経営陣は 経験豊富 とはみなされません ( 0.7年の平均在職年数)。これは新しいチームを示唆しています。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | データなし | データなし | |
| Executive Director & Executive Deputy GM | 4.7yrs | HK$975.00k | 0.0073% HK$ 482.7k | |
| CEO & Executive Director | less than a year | データなし | データなし | |
| Independent Non-Executive Director | 7.2yrs | HK$288.00k | データなし | |
| Independent Non-Executive Director | 11.6yrs | HK$288.00k | データなし | |
| Non-Executive Director | 2.3yrs | データなし | データなし | |
| Independent Non-Executive Director | 1.7yrs | HK$240.00k | データなし |
2.3yrs
平均在職期間
53yo
平均年齢
経験豊富なボード: 3613の 取締役会 は 経験豊富 ではない ( 2.3年の平均在任期間) ため、新しい取締役会が必要であると考えられます。